Nishadil
Signup Signin
Delhi | 25°C (windy)
Breakthrough in Lung Cancer Treatment: Positive Phase 3 OPTITROP-Lung04 Trial Results for Sacituzumab Tirumotecan Unveiled

Breakthrough in Lung Cancer Treatment: Positive Phase 3 OPTITROP-Lung04 Trial Results for Sacituzumab Tirumotecan Unveiled
Enhertu's Triumph: AstraZeneca and Daiichi Sankyo Unveil Pivotal Phase 3 Data, Reshaping Cancer Care

Enhertu's Triumph: AstraZeneca and Daiichi Sankyo Unveil Pivotal Phase 3 Data, Reshaping Cancer Care
A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025

A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025
Breakthrough in Breast Cancer Treatment: Kelun Biotech's Sacituzumab Tirumotecan Shines at ESMO 2025

Breakthrough in Breast Cancer Treatment: Kelun Biotech's Sacituzumab Tirumotecan Shines at ESMO 2025
A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients

A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients
Glenmark Forges Major Oncology Alliance with Hengrui for Advanced Cancer Therapy

Glenmark Forges Major Oncology Alliance with Hengrui for Advanced Cancer Therapy
Corbus Pharmaceuticals' Lead Drug Receives Esteemed FDA Fast Track Designation

Corbus Pharmaceuticals' Lead Drug Receives Esteemed FDA Fast Track Designation
BioNTech Soars: Landmark Phase 3 Success for Breast Cancer Therapy

BioNTech Soars: Landmark Phase 3 Success for Breast Cancer Therapy
Load more..